• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

SASAKI HIROSHI  佐々木 浩

ORCIDConnect your ORCID iD *help
… Alternative Names

SASAKI Hiroshi  佐々木 浩

Less
Researcher Number 80432491
Other IDs
Affiliation (Current) 2025: 大阪医科薬科大学, 医学部, 非常勤講師
Affiliation (based on the past Project Information) *help 2023: 大阪医科薬科大学, 医学部, 非常勤講師
2021 – 2022: 大阪医科薬科大学, 医学部, 講師
2015 – 2020: 大阪医科大学, 医学部, 講師
2017: 大阪医科大学, 医学部, 助教
2014: 大阪医科大学, 医学部, 助教
2007 – 2012: 大阪医科大学, 医学部, 助教
Review Section/Research Field
Principal Investigator
Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Except Principal Investigator
Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords
Principal Investigator
卵巣癌 / 脂肪細胞 / 肥満 / オルガノイド / がん微小環境 / アディポカイン / がん / がん関連繊維芽細胞 / FABP4 / 腫瘍随伴マクロファージ … More / 子宮体がん / 癌関連繊維芽細胞 / microRNA / 癌微小環境 / エキソソーム / NFкB / NFκB / VEGF / NF・B / Akt / プラチナ耐性 / トポテカン / シスプラチン … More
Except Principal Investigator
卵巣癌 / EMT / CD24 / 子宮頸癌 / 癌幹細胞 / GPR30 / マイクロRNA / miRNA / E-cadherin / 上皮間葉形質転換 / 子宮内膜癌 / BNCT / エクソソーム / 子宮頚癌 / 子宮体癌 / 高分子ミセル / 婦人科悪性腫瘍 / EMT現象 / 婦人科癌 / 浸潤・転移 / 白金製剤耐性卵巣癌 / EGFR / 抗癌剤耐性 / snail / 癌 / MPA / フェロトーシス / PDXモデル / PARP阻害剤 / 同時化学放射線療法 / LAT-1 / 硼素中性子捕捉療法 / LAT1 / ホウ素中性子補足療法 / オルガノイド / Te-EVs / 腫瘍直接移植モデル / EVs / 臨床腫瘍直接移植モデル / PDX / PDX / 細胞外小胞 / 癌免疫治療 / 放射線治療 / T細胞 / 免疫応答 / 腫瘍免疫 / エリブリン / 難治性卵巣癌 / 硼素内包高分子ミセル / 硼素化合物 / 子宮頸がん / Endothelinー2 / 上皮間葉形態転換 / ニッチ / 上皮・間葉形態転換 / ドラッグデリバリーシステム / GPIアンカー型蛋白質 / ラフト形成 / GPIアンカー型タンパク質 / EMT / CD24 / MET / 化学療法抵抗性 / lipid raft / exosome / 癌関連線維芽細胞 / 肥満 / 子宮体がん / 癌関連繊維芽細胞 / エキソソーム / mi RNA / 抗がん剤 / 卵巣保護 / AMH / テストステロン / 顆粒膜細胞 / アルキル化剤 / 卵巣毒性 / ミセル / EMT, 高分子ミセル / CD24, 婦人科悪性腫瘍 / Slug / E-cadherino / Epithelial Mesenchymal Transition / E-chadherin / Snail / 薬剤耐性 / 幹細胞 / VEGF / Akt-mTOR-HIF / 上皮性卵巣癌 / プロゲステロン受容体 / slug / 維持療法 / 抗血管新生治療 / 婦人科腫瘍学 / イレッサ / 分子標的治療 / 耐性卵巣癌 / アデノウイルス / IAPファミリー / SiRNA / NFkB / プロモーターマイクロアレイ / アポトーシス / タキソール / シスプラチン / トランスレーショナルリサーチ / シグナル伝達 / 薬剤反応性 / マイクロアレイ Less
  • Research Projects

    (25 results)
  • Research Products

    (47 results)
  • Co-Researchers

    (24 People)
  •  卵巣癌PDXモデルを用いたPARP阻害剤耐性解除機構の解明と個別化治療への応用

    • Principal Investigator
      大道 正英
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  MPA抵抗性子宮体癌のレドックス機構に着目した妊孕能温存に向けた新規治療の開発

    • Principal Investigator
      林 正美
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  硼素中性子捕捉療法とLAT1を介した化学療法を併用する子宮頸癌の新たな治療戦略

    • Principal Investigator
      寺田 信一
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  Elucidation of the mechanism of cancer invasion and metastasis by adipocytes using ovarian cancer organoidsPrincipal Investigator

    • Principal Investigator
      HIROSHI SASAKI
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  Establishment of personalized medicine for refractory ovarian cancer using 3D organoid culture

    • Principal Investigator
      Ohmichi Masahide
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  Research on treatment of cervical cancer by combined cancer immunotherapy

    • Principal Investigator
      Hayashi Masami
    • Project Period (FY)
      2019 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  Analysis of extracellular vesicles using patient derived xenograft

    • Principal Investigator
      Tomohito Tanaka
    • Project Period (FY)
      2019 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical and Pharmaceutical University
  •  Target therapy of ovarian cancer including immunotherapy via Eribulin

    • Principal Investigator
      FUJIWARA SATOE
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Osaka Medical College
  •  Research for cancer microenvironment via FABP4 in endometrial cnacerPrincipal Investigator

    • Principal Investigator
      Sasaki Hiroshi
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT

    • Principal Investigator
      Ohmichi Masahide
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Treatment strategy of boron neutron capture therapy in cervical cancer

    • Principal Investigator
      Tsunetoh Satoshi
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer

    • Principal Investigator
      Terai Yoshito
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kobe University
      Osaka Medical College
  •  activation regulatory mechanism of cancer fibroblast by obesity

    • Principal Investigator
      Takai Masaaki
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  A novel approach for cervical cancer using exosome

    • Principal Investigator
      Hayashi Masami
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer

    • Principal Investigator
      Tanaka Yoshimichi
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity

    • Principal Investigator
      Tanabe Akiko
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer

    • Principal Investigator
      Fujiwara Satoe
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.Principal Investigator

    • Principal Investigator
      SASAKI HIROSHI
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  EMT including cancer stem cells regulates invasion and metastasis of uterine endometrial cancer.

    • Principal Investigator
      TERAI Yoshito
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Developing of polymeric micelle for molecular targeting to cancer stem cells in ovarian cancer patients.

    • Principal Investigator
      OHMICHI Masahide
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Analysis of the role of MPA as a molecular-targeted therapy in endometrial cancer.

    • Principal Investigator
      KANEMURA Masanori
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Basic research of cancer stem cell for therapeutic target in cisplatin-resistant ovarian cancer.

    • Principal Investigator
      TANABE Akiko
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Analysis of a new molecule target action of topotecan using a promoter microarrayPrincipal Investigator

    • Principal Investigator
      SASAKI Hiroshi
    • Project Period (FY)
      2009 – 2010
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Basic research of either bevacizumab or gefitinib in platinum-resistant ovarian cancer.

    • Principal Investigator
      TERAI Yoshito
    • Project Period (FY)
      2007 – 2009
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College
  •  Analysis of chemo-resistance genes with promoter micro-array in ovarian cancer

    • Principal Investigator
      OHMICHI Masahide
    • Project Period (FY)
      2006 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Osaka Medical College

All 2022 2021 2020 2019 2018 2017 2014 2012 2011 2010 2009 2008 Other

All Journal Article Presentation

  • [Journal Article] Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review2022

    • Author(s)
      Tanaka Tomohito、Nishie Ruri、Ueda Shoko、Miyamoto Shunsuke、Hashida Sousuke、Konishi Hiromi、Terada Shinichi、Kogata Yuhei、Sasaki Hiroshi、Tsunetoh Satoshi、Taniguchi Kohei、Komura Kazumasa、Ohmichi Masahide
    • Journal Title

      Journal of Clinical Medicine

      Volume: 11 Issue: 9 Pages: 2606-2606

    • DOI

      10.3390/jcm11092606

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K09655, KAKENHI-PROJECT-19K09838
  • [Journal Article] Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma2022

    • Author(s)
      Maruoka Hiroshi、Tanaka Tomohito、Murakami Hikaru、Tsuchihashi Hiromitsu、Toji Akihiko、Nunode Misa、Daimon Atsushi、Miyamoto Shunsuke、Nishie Ruri、Ueda Shoko、Hashida Sousuke、Terada Shinichi、Konishi Hiromi、Kogata Yuhei、Taniguchi Kohei、Komura Kazumasa、Ohmichi Masahide
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 23 Issue: 24 Pages: 15715-15715

    • DOI

      10.3390/ijms232415715

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K09655, KAKENHI-PROJECT-19K09838
  • [Journal Article] Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review2021

    • Author(s)
      Tanaka Tomohito、Nishie Ruri、Ueda Shoko、Miyamoto Shunsuke、Hashida Sousuke、Konishi Hiromi、Terada Shinichi、Kogata Yuhei、Sasaki Hiroshi、Tsunetoh Satoshi、Taniguchi Kohei、Komura Kazumasa、Ohmichi Masahide
    • Journal Title

      International Journal of Molecular Sciences

      Volume: 22 Issue: 17 Pages: 9369-9369

    • DOI

      10.3390/ijms22179369

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09838
  • [Journal Article] Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer2020

    • Author(s)
      Maeda K, Sasaki H, Ueda S, Miyamoto S, Terada S, Konishi H, Kogata Y, Ashihara K, Fujiwara S, Tanaka Y, Tanaka T, Hayashi M, Ito Y, Kondo Y, Ochiya T, Ohmichi M
    • Journal Title

      J Ovarian Res.

      Volume: 13 Issue: 1 Pages: 47-47

    • DOI

      10.1186/s13048-020-00648-1

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09838, KAKENHI-PROJECT-16K10482, KAKENHI-PROJECT-17K11303
  • [Journal Article] Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer2020

    • Author(s)
      Ashihara K, Terai Y, Tanaka T, Tanaka Y, Fujiwara S, Maeda K, Tunetoh S, Sasaki H, Hayashi M, Ohmichi M.
    • Journal Title

      Oncol Lett.

      Volume: 19 Pages: 1872-1880

    • DOI

      10.3892/ol.2020.11279

    • NAID

      120006873100

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09838, KAKENHI-PROJECT-17K11303, KAKENHI-PROJECT-17K11304
  • [Journal Article] Intraperitoneal cytology after laparoscopic radical hysterectomy with vaginal closure without the use of a manipulator for cervical cancer: a retrospective observational study2019

    • Author(s)
      Tanaka T, Miyamoto S, Terada S, Kogata Y, Sasaki H, Tsunetoh S, Yamada T, Ohmichi M
    • Journal Title

      Cancer Manag Res.

      Volume: 11 Pages: 7015-7020

    • DOI

      10.2147/cmar.s210277

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09838
  • [Journal Article] A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma2018

    • Author(s)
      Maeda Kazuya、Terai Yoshito、Terada Shinichi、Maruoka Hiroshi、Kogata Yuhei、Ashihara Keisuke、Tanaka Yoshimichi、Tanaka Tomohito、Sasaki Hiroshi、Tsunetoh Satoshi、Yamada Takashi、Ohmichi Masahide
    • Journal Title

      Journal of Ovarian Research

      Volume: 11 Issue: 1 Pages: 74-74

    • DOI

      10.1186/s13048-018-0446-4

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-16K11165
  • [Journal Article] CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.2017

    • Author(s)
      Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.
    • Journal Title

      Oncol Rep

      Volume: - Issue: 6 Pages: 3189-3200

    • DOI

      10.3892/or.2017.5583

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26462541, KAKENHI-PROJECT-16K11162, KAKENHI-PROJECT-16K11165, KAKENHI-PROJECT-17K11304
  • [Journal Article] The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer.2017

    • Author(s)
      anaka T, Terai Y, Ashihara K, Fujiwara S, Tanaka Y, Sasaki H, Tsunetoh S, Ohmichi M
    • Journal Title

      PLoS One

      Volume: 12 Issue: 5 Pages: e0177019-e0177019

    • DOI

      10.1371/journal.pone.0177019

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26462541
  • [Journal Article] Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.2014

    • Author(s)
      Kawaguchi H, Terai Y, Tanabe A, Sasaki H, Takai M, Fujiwara S, Ashihara K, Tanaka Y, Tanaka T, Tsunetoh S, Kanemura M, Ohmichi M.
    • Journal Title

      J Ovarian Res.

      Volume: 7 Issue: 1 Pages: 38-38

    • DOI

      10.1186/1757-2215-7-38

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
  • [Journal Article] The EMT (epithelial mesenchymaltransition protein expression indicates the metastasicc status and progesis in patient with ovarian cancer2014

    • Author(s)
      Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
    • Journal Title

      Journal of ovarian research

      Volume: 76 Issue: 1 Pages: 1-5

    • DOI

      10.1186/1757-2215-7-76

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24592536, KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
  • [Journal Article] GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.2012

    • Author(s)
      Fujiwara S, Terai Y(分担)、Kawaguchi H, Takai M, Yoo S, Tanaka Y, Tanaka T,Tsunetoh S, Sasaki H (分担)、Kanemura M (分 担)、Tanabe A (分担)、Ohmichi M (代表)
    • Journal Title

      Journal of Ovarian Research

      Volume: 5(1) Pages: 35-44

    • Data Source
      KAKENHI-PROJECT-22659303
  • [Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.2011

    • Author(s)
      Tanaka Y, Terai Y*, Tanabe A, Sasaki H, Sekijima T, Fujiwara S, Yamashita Y, Kanemura M, Ueda M, Sugita M, Franklin WA, Ohmichi M.
    • Journal Title

      Cancer Biol Ther

      Volume: 11 Pages: 50-57

    • Data Source
      KAKENHI-PROJECT-22591869
  • [Journal Article] Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer.2011

    • Author(s)
      Tanaka Y, Sasaki H, Ohmichi M.
    • Journal Title

      Cancer Biol Ther. 11(1)

      Pages: 50-57

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Journal Article] Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cances.2010

    • Author(s)
      佐々木浩, 恒遠啓示
    • Journal Title

      Cancer Biology and Therapy.

      Volume: 11 Pages: 1137-1137

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Journal Article] Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers.2010

    • Author(s)
      Tsunetoh S, Sasaki H, Ohmichi M.
    • Journal Title

      Cancer Biol Ther. 10(11)

      Pages: 1137-1146

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Journal Article] Long-term follow-up of neoadjuvant intraarterial chemotherapu using an original four-lumen double balloon(4L-DB) catheter for locally advanced uterine cervical cancer.2009

    • Author(s)
      Terai Y, Kanemura M, Sasaki H, Tsunetoh S, Tanaka Y, Yamashita Y, Yamamoto K, Narabayashi I, Ohmichi M.
    • Journal Title

      Int J Clin Oncol 14

      Pages: 56-62

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Journal Article] Defference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines2008

    • Author(s)
      佐々木 浩
    • Journal Title

      Oncogene 27

      Pages: 2737-2745

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Journal Article] Maintenance treatment with bevacizumab prolong survival in an in vivo ovarian cancer model.2008

    • Author(s)
      Mabuchi S, Terai Y, Morishige K, Kimura-Tanabe A, Sasaki H, Kanemura M, Tsunetoh S, Tanaka Y, Sakata Y, Burger R, Kimura T, Ohmichi M.
    • Journal Title

      Clin Cancer Res 14(23)

      Pages: 7781-7789

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Presentation] 進行婦人科癌患者における腹水・胸水を用いた患者由来がんモデルの作製と検証2022

    • Author(s)
      西江瑠璃、田中智人、村上 暉、上田尚子、橋田宗祐、宮本瞬輔、寺田信一、古形祐平、藤原聡枝、田中良道、恒遠啓示、佐々木浩、山田隆司、大道正英
    • Organizer
      第64回日本婦人科腫瘍学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09838
  • [Presentation] 内臓脂肪は卵巣癌の生命予後に影響するか2019

    • Author(s)
      丸岡寛、佐々木浩
    • Organizer
      第34回日本女性医学学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K11303
  • [Presentation] 内臓脂肪および皮下脂肪が腹腔鏡下子宮体癌手術に及ぼす影響に関する検討2019

    • Author(s)
      丸岡寛、佐々木浩
    • Organizer
      第59回日本産婦人科内視鏡学会
    • Data Source
      KAKENHI-PROJECT-17K11303
  • [Presentation] New approaches using exosome for cervical cancer treatment.2019

    • Author(s)
      Hiromi Konishi, Masami Hayashi, Shinichi Terada, Kana Kokunai, Natsuho Nakamura, Sayaka Taga, Satoe Fujiwara, Hiroshi Sasaki, Yoshito Terai, Masahide Ohmichi
    • Organizer
      第71回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-19K09791
  • [Presentation] 内臓脂肪と子宮体癌の臨床病理学的特徴の関係2018

    • Author(s)
      丸岡寛、佐々木浩
    • Organizer
      第33回日本女性医学学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K11303
  • [Presentation] GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer2018

    • Author(s)
      藤原聡枝 田中良道 田中智人 恒遠啓示 佐々木浩 寺井義人 大道正英
    • Organizer
      International Gynecologic Cancer Society 2018
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K10738
  • [Presentation] 子宮内膜症合併卵巣がんと脂質異常症は関連しているか?2018

    • Author(s)
      佐々木浩
    • Organizer
      第70回日本産科婦人科学会
    • Data Source
      KAKENHI-PROJECT-16K11163
  • [Presentation] 子宮内膜症合併卵巣がんと脂質異常症は関連しているか?2018

    • Author(s)
      佐々木浩
    • Organizer
      第70回日本産科婦人科学会
    • Data Source
      KAKENHI-PROJECT-17K11303
  • [Presentation] MicroRNA-22を介した子宮頸癌の分子標的治療への応用2017

    • Author(s)
      中村真由美、林正美、橋田宗祐、丸岡寛、小西博巳、前田和也、田中良道、佐々木浩、寺井義人、大道正英
    • Organizer
      日本産婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-16K11164
  • [Presentation] 生活習慣病からみた子宮体がんの臨床病理学的特徴2017

    • Author(s)
      佐々木浩
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-16K11163
  • [Presentation] 難治性卵巣癌モデルマウスに対するCD24を標的とした高分子ミセルを用いた新規治療2017

    • Author(s)
      芦原 敬允, 寺井 義人, 土橋 裕允, 藤原 聡枝, 田中 良道, 田中 智人, 恒遠 啓示, 佐々木 浩, 林 正美, 大道 正英
    • Organizer
      第69回日本産科婦人科学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K11304
  • [Presentation] 生活習慣病からみた子宮体がんの臨床病理学的特徴2017

    • Author(s)
      佐々木浩
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-17K11303
  • [Presentation] 子宮体癌における EMT のマーカーとしての CD24 の有用性2012

    • Author(s)
      田中良道、寺井義人、斎藤奈津穂、川口 浩史、中村路彦、兪 史夏、藤原聡枝、 佐々木浩、恒遠啓示、金村昌徳、田辺晃 子、大道正英
    • Organizer
      第64回日本産科婦人科学会
    • Place of Presentation
      神戸
    • Data Source
      KAKENHI-PROJECT-22591869
  • [Presentation] エストロゲン受容体GPR30の子宮内膜癌における制御機構の解明2011

    • Author(s)
      佐々木浩、金村昌徳大道正英
    • Organizer
      第63回日本産婦人科学会学術講演会
    • Place of Presentation
      大阪
    • Data Source
      KAKENHI-PROJECT-21592148
  • [Presentation] 子宮内膜癌に対するmedroxyprogesterone acetate(MPA)の作用機序2010

    • Author(s)
      佐々木浩
    • Organizer
      第61回日本産科婦人科学会総会・学術講演会
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Presentation] 卵巣癌におけるGPR30の免疫組織化学的検討2010

    • Author(s)
      佐々木浩
    • Organizer
      癌治療学会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2010-10-28
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Presentation] 卵巣癌における抗癌剤感受性に基づいた新規 molecular marker としてのNFκB の意義2010

    • Author(s)
      佐々木浩
    • Organizer
      第62回日本産科婦人科学会総会・学術講演会
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Presentation] 子宮内膜癌に対するMPAの作用機序2009

    • Author(s)
      佐々木浩, 金村昌徳
    • Organizer
      第61回 日本産科婦人科学会総会学術講演会
    • Place of Presentation
      京都
    • Year and Date
      2009-04-05
    • Data Source
      KAKENHI-PROJECT-21592148
  • [Presentation] Topoisomerase linhibitor であるtopotecan のCDDP 耐性解除機構2009

    • Author(s)
      佐々木浩
    • Organizer
      第60回日本産科婦人科学会総会・学術講演会
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Presentation] 当科における難治性卵巣癌(明細胞腺癌、粘液性腺癌)の治療成績2009

    • Author(s)
      佐々木浩
    • Organizer
      第47回日本癌治療学会学術集会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2009-10-22
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Presentation] 子宮内膜癌に対する medroxyprogesterone acetate(MPA)の作用機序2009

    • Author(s)
      佐々木浩
    • Organizer
      第61回 日本産科婦人科学会学術講演会
    • Place of Presentation
      国立京都国際会館
    • Year and Date
      2009-04-03
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Presentation] 当科における白金製剤耐性卵巣癌におけるGemcitabine単剤療法の有効性2008

    • Author(s)
      佐々木浩, 加藤壮介, 川辺紗智子, 藤岡聡枝, 田中良道, 恒遠啓示, 金村昌徳, 田辺晃子, 寺井義人, 大道正英
    • Organizer
      第46回日本癌治療学会総会
    • Place of Presentation
      名古屋国際会議場
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Presentation] 卵巣癌におけるEGFR遺伝子のmutation、発現とAKT、ERKの活性化の臨床的意義」2008

    • Author(s)
      田中良道, 寺井義人, 加藤壮介, 川辺紗智子, 藤岡聡枝, 佐々木浩, 恒遠啓示, 金村昌徳, 田辺晃子, 大道正英
    • Organizer
      第46回日本癌治療学会総会
    • Place of Presentation
      名古屋国際会議場
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Presentation] topoisomerase I inhibitorであるtopotecanはin vivoにおいてcddp耐性を解除するか?2008

    • Author(s)
      恒遠啓示, 寺井義人, 金村昌徳, 竹原幹雄, 佐々木浩, 田中良道, 田辺晃子, 大道正英
    • Organizer
      第60回日本産科婦人科学会総会・学術講演会
    • Place of Presentation
      パシフィコ横浜
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Presentation] Topoisomerase 1 inhibitorであるtopotecanのCDDP耐性解除機構2008

    • Author(s)
      佐々木浩, 寺井義人, 金村昌徳, 竹原幹雄, 恒遠啓示, 田中良道, 田辺晃子, 大道正英
    • Organizer
      第60回日本産科婦人科学会総会・学術講演会
    • Place of Presentation
      パシフィコ横浜
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Presentation] Topoisomerase 1 inhibitorであるtopotecanのin vivoにおけるCDDP耐性を解除の解明2008

    • Author(s)
      恒遠啓示, 寺井義人, 川辺紗智子, 加藤壮介, 藤岡聡枝, 田中良道, 佐々木浩, 金村昌徳, 田辺晃子, 大道正英
    • Organizer
      第46回日本癌治療学会総会
    • Place of Presentation
      名古屋国際会議場
    • Data Source
      KAKENHI-PROJECT-19591946
  • [Presentation] topoisomerase I inhibitor であるtopotecan はin vivo においてCDDP耐性を解除するか?2008

    • Author(s)
      恒遠啓示、佐々木浩
    • Organizer
      第60回日本産科婦人科学会総会・学術講演会
    • Data Source
      KAKENHI-PROJECT-21791578
  • [Presentation] 卵巣癌におけるEGFR 遺伝子変異とその下流シグナル分子の発現解析

    • Author(s)
      田中良道、佐々木浩、大道正英
    • Data Source
      KAKENHI-PROJECT-21791578
  • 1.  OHMICHI Masahide (10283764)
    # of Collaborated Projects: 24 results
    # of Collaborated Products: 27 results
  • 2.  TERAI Yoshito (90278531)
    # of Collaborated Projects: 19 results
    # of Collaborated Products: 20 results
  • 3.  Hayashi Masami (00551748)
    # of Collaborated Projects: 17 results
    # of Collaborated Products: 5 results
  • 4.  Tanaka Yoshimichi (10625502)
    # of Collaborated Projects: 16 results
    # of Collaborated Products: 15 results
  • 5.  TANABE Akiko (70454543)
    # of Collaborated Projects: 15 results
    # of Collaborated Products: 12 results
  • 6.  Tsunetoh Satoshi (70388255)
    # of Collaborated Projects: 14 results
    # of Collaborated Products: 11 results
  • 7.  Fujiwara Satoe (90707960)
    # of Collaborated Projects: 14 results
    # of Collaborated Products: 5 results
  • 8.  KANEMURA Masanori (40298782)
    # of Collaborated Projects: 9 results
    # of Collaborated Products: 14 results
  • 9.  Tomohito Tanaka (90411363)
    # of Collaborated Projects: 9 results
    # of Collaborated Products: 8 results
  • 10.  兪 史夏 (80625674)
    # of Collaborated Projects: 6 results
    # of Collaborated Products: 0 results
  • 11.  古形 祐平 (80829953)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 4 results
  • 12.  SAKATA Masahiro (10260639)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 13.  TAKEHARA Mikio (40298766)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 14.  劉 昌恵 (00849581)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 15.  YAMASHITA Yoshiki (50268207)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 16.  KAMEGAI Hideki (30204639)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 17.  TASAKA Keiichi (50155058)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 18.  TAHARA Masahiro (00294091)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 19.  HAYAKAWA Jun (80397736)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 20.  HASHOMOTO Namiko (60379253)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 21.  Takai Masaaki (90770933)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 22.  寺田 信一 (60861242)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 23.  田路 明彦 (60965929)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 24.  上田 尚子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi